A Comparative Randomized Clinical Study Assessing the Efficacy of a 1% Selenium Disulfide-Based Shampoo versus 2% Ketoconazole Shampoo in Subjects with Moderate to Severe Scalp Seborrheic Dermatitis

一项比较性随机临床研究,旨在评估1%二硫化硒洗发水与2%酮康唑洗发水治疗中重度头皮脂溢性皮炎患者的疗效。

阅读:1

Abstract

INTRODUCTION: Scalp seborrheic dermatitis (SSD) is a chronic, relapsing, and inflammatory condition impacting quality of life (QoL). This study evaluated the efficacy and impact on QoL of a 1% selenium disulphide-containing shampoo (SeS(2) shampoo) compared to a 2% ketoconazole shampoo. METHODS: This multi-centric, double-blinded, randomized 4-week study was conducted in 64 adult subjects with moderate to severe SSD (SSD severity score (SSSD) > 6). Shampoo was applied on the scalp and hair, according to product indications. Clinical examinations at baseline and on Day (D) 3, 7, 14, and 28 included the assessment of SSSD, total scales score (TSS, sum of adherent, and non-adherent scales), erythema, irritation, seborrhea, and itching. Self-evaluations included QoL and hair quality assessment (scales and greasiness). RESULTS: The SSSD improved in both groups as early as D3, after one application of shampoo. This significant (p < 0.001) improvement was -71% for SeS(2) and -69% for ketoconazole at D28. The decrease of the TSS was significant (p < 0.001) at D28 in both groups (-75% SeS(2) and -68% for ketoconazole). The SSSD severity of all subjects decreased to mild at D28. Signs and symptoms had significantly (p < 0.001) improved in both groups after 28 days. QoL improved earlier with SeS(2) than with ketoconazole shampoo. The cosmetic acceptability of SeS(2) shampoo was higher than that of ketoconazole shampoo. Both shampoos were very well tolerated. CONCLUSION: SeS(2) shampoo is a reliable and well-tolerated alternative care to ketoconazole shampoo in patients with moderate to severe scalp seborrheic dermatitis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。